Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 5Active not recruiting 4Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 162Neoplasms 119Carcinoma, Non-Small-Cell Lung 93Prostatic Neoplasms 86Colorectal Neoplasms 86Lung Neoplasms 78Leukemia, Myeloid, Acute 54Carcinoma, Hepatocellular 53Pancreatic Neoplasms 46Neoplasm Metastasis 44Multiple Myeloma 39Recurrence 36Triple Negative Breast Neoplasms 32Squamous Cell Carcinoma of Head and Neck 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Ovarian Neoplasms 29Melanoma 29Brain Neoplasms 29Glioblastoma 28Uterine Cervical Neoplasms 27Stomach Neoplasms 27Head and Neck Neoplasms 27Rectal Neoplasms 25Small Cell Lung Carcinoma 23Carcinoma, Renal Cell 22Glioma 21Sarcoma 19Lymphoma, B-Cell 19Endometrial Neoplasms 19Lymphoma, Follicular 18

Interventions

gadopiclenol 1gadobutrol 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Meningeal Neoplasms × 90 days × Clear all
NCT07415018 2026-04-14

Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
40 enrolled

Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡